| Sector | Prev | Curr ▼ | Delta |
|---|---|---|---|
| Pharmaceuticals & Biotechnology | 49.4% | 38.7% | ▼ -10.6% |
| Telecom - Services | 7.1% | 9.6% | ▲ +2.4% |
| Food Products | 9.3% | 8.7% | ▼ -0.5% |
| Healthcare Services | 8.9% | 8.7% | ▼ -0.2% |
| Insurance | 8.2% | 3.7% | ▼ -4.4% |
| Retailing | 3.7% | 0.0% | ▼ -3.7% |
| Sector | Prev | Curr ▼ | Delta |
|---|---|---|---|
| Pharmaceuticals & Biotechnology | 38.7% | 39.8% | ▲ +1.1% |
| Healthcare Services | 8.7% | 11.0% | ▲ +2.3% |
| Telecom - Services | 9.6% | 10.8% | ▲ +1.2% |
| Food Products | 8.7% | 9.4% | ▲ +0.7% |
| Insurance | 3.7% | 0.0% | ▼ -3.7% |
Comparing May 2026 → Jun 2026
| # | Stock | Sector | Weight (Jun 2026) |
|---|---|---|---|
| 1 | Concord Biotech Limited ₹34.56 Cr |
Pharmaceuticals & Biotechnology | 8.84% |
| 2 | Max Healthcare Institute Limited ₹7.92 Cr |
Healthcare Services | 2.03% |
| # | Stock | Sector | Last Weight (May 2026) |
|---|---|---|---|
| 1 | Anthem Biosciences Limited ₹32.25 Cr |
Pharmaceuticals & Biotechnology | 8.66% |
| 2 | HDFC Life Insurance Company Limited ₹13.89 Cr |
Insurance | 3.73% |
| # | Stock | Sector | May 2026 | Jun 2026 | Change |
|---|---|---|---|---|---|
| 1 | HFCL Limited ₹42.09 Cr |
Telecom - Services | 9.55% | 10.76% | +1.21% |
| 2 | Zydus Wellness Limited ₹36.93 Cr |
Food Products | 8.74% | 9.44% | +0.70% |
| 3 | SMS Pharmaceuticals Limited ₹31.88 Cr |
Pharmaceuticals & Biotechnology | 7.66% | 8.15% | +0.49% |
| 4 | Alivus Life Sciences ₹28.48 Cr |
Pharmaceuticals & Biotechnology | 6.98% | 7.28% | +0.30% |
| 5 | Aurobindo Pharma Limited ₹20.39 Cr |
Pharmaceuticals & Biotechnology | 4.95% | 5.21% | +0.26% |
| 6 | Aster DM Healthcare Limited ₹35.04 Cr |
Healthcare Services | 8.73% | 8.96% | +0.23% |
| 7 | Strides Pharma Science Limited ₹11.18 Cr |
Pharmaceuticals & Biotechnology | 2.63% | 2.86% | +0.23% |
| 8 | GlaxoSmithKline Pharmaceuticals Limited ₹7.96 Cr |
Pharmaceuticals & Biotechnology | 1.93% | 2.04% | +0.11% |
| # | Stock | Sector | May 2026 | Jun 2026 | Change |
|---|---|---|---|---|---|
| 1 | Pfizer Limited ₹21.29 Cr |
Pharmaceuticals & Biotechnology | 5.92% | 5.44% | -0.48% |
11 stocks — Jun 2026
| # | Stock | Sector | Cap | Weight & Value |
|---|---|---|---|---|
| 1 |
₹42.09 Cr |
Telecom - Services |
10.76%
|
|
| 2 |
₹36.93 Cr |
Food Products |
9.44%
|
|
| 3 |
₹35.04 Cr |
Healthcare Services |
8.96%
|
|
| 4 |
₹34.56 Cr |
Pharmaceuticals & Biotechnology |
8.84%
|
|
| 5 |
₹31.88 Cr |
Pharmaceuticals & Biotechnology |
8.15%
|
|
| 6 |
₹28.48 Cr |
Pharmaceuticals & Biotechnology |
7.28%
|
|
| 7 |
₹21.29 Cr |
Pharmaceuticals & Biotechnology |
5.44%
|
|
| 8 |
₹20.39 Cr |
Pharmaceuticals & Biotechnology |
5.21%
|
|
| 9 |
₹11.18 Cr |
Pharmaceuticals & Biotechnology |
2.86%
|
|
| 10 |
₹7.96 Cr |
Pharmaceuticals & Biotechnology |
2.04%
|
Disclaimer: Data sourced from individual AMC monthly portfolio disclosures, as mandated by SEBI/AMFI. While we strive for accuracy, errors in parsing or presentation may occasionally occur. This is not investment advice. Please consult a SEBI-registered investment adviser before making any investment decisions.
Found a discrepancy or have feedback? Contact Us — we read every message personally.